Skip to main content
Top
Published in: Pediatric Cardiology 4/2017

Open Access 01-04-2017 | Original Article

Regression and Complications of z-score-Based Giant Aneurysms in a Dutch Cohort of Kawasaki Disease Patients

Authors: S. M. Dietz, I. M. Kuipers, J. C. D. Koole, J. M. P. J. Breur, Z. Fejzic, S. Frerich, M. Dalinghaus, A. A. W. Roest, B. A. Hutten, T. W. Kuijpers

Published in: Pediatric Cardiology | Issue 4/2017

Login to get access

Abstract

Kawasaki disease (KD) is a pediatric vasculitis. Its main complication is the development of coronary artery aneurysms (CAA), with giant CAA at the end of the spectrum. We evaluated regression and event-free rates in a non-Asian cohort of patients with giant CAA using the current z-scores adjusted for body surface area instead of absolute diameters. KD patients with giant CAA (z-score ≥10) visiting our outpatient clinic between January 1999 and September 2015 were included. Patient characteristics and clinical details were extracted from medical records. Regression was defined as all coronary arteries having a z-score of ≤3. A major adverse event was defined as cardiac death, myocardial infarction, cardiogenic shock, or any coronary intervention. Regression-free and event-free rates were calculated using the Kaplan–Meier method. We included 52 patients with giant CAA of which 45 had been monitored since the acute phase. The 1-, 2-, and 5-year regression-free rates were 0.86, 0.78, and 0.65, respectively. The 5-year, 10-year, and 15-year event-free rates were 0.79, 0.75, and 0.65, respectively. Four children, whose CAA would not have been classified as ‘giant’ based on absolute diameters instead of z-scores, had experienced an event during follow-up. Conclusion: We found a high percentage of children in whom the lumen of giant CAA completely normalized. Four children not classified as ‘giant’ based on absolute diameters with z-scores of ≥10 experienced a cardiac event. Hence, the use of z-scores seems to be justified.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kawasaki T (1967) [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. [Allergy]=Arerugi 16:178–222 Kawasaki T (1967) [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. [Allergy]=Arerugi 16:178–222
2.
3.
go back to reference Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP, Mason WH, Meissner HC, Rowley AH, Shulman ST, Reddy V, Sundel RP, Wiggins JW, Colton T, Melish ME, Rosen FS (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633–1639CrossRefPubMed Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP, Mason WH, Meissner HC, Rowley AH, Shulman ST, Reddy V, Sundel RP, Wiggins JW, Colton T, Melish ME, Rosen FS (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633–1639CrossRefPubMed
4.
go back to reference Manlhiot C, Millar K, Golding F, McCrindle BW (2010) Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease. Pediatr Cardiol 31:242–249CrossRefPubMed Manlhiot C, Millar K, Golding F, McCrindle BW (2010) Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease. Pediatr Cardiol 31:242–249CrossRefPubMed
5.
go back to reference Tsuda E, Hamaoka K, Suzuki H, Sakazaki H, Murakami Y, Nakagawa M, Takasugi H, Yoshibayashi M (2014) A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease. Am Heart J 167:249–258CrossRefPubMed Tsuda E, Hamaoka K, Suzuki H, Sakazaki H, Murakami Y, Nakagawa M, Takasugi H, Yoshibayashi M (2014) A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease. Am Heart J 167:249–258CrossRefPubMed
6.
go back to reference McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M, Vetter VL, Gersony WM, Mitchell PD, Newburger JW, Pediatric Heart Network I (2007) Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116:174–179CrossRefPubMed McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M, Vetter VL, Gersony WM, Mitchell PD, Newburger JW, Pediatric Heart Network I (2007) Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116:174–179CrossRefPubMed
7.
go back to reference Group JCSJW (2014) Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version. Circ J 78:2521–2562CrossRef Group JCSJW (2014) Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version. Circ J 78:2521–2562CrossRef
8.
go back to reference Chih WL, Wu PY, Sun LC, Lin MT, Wang JK, Wu MH (2016) Progressive coronary dilatation predicts worse outcome in Kawasaki disease. J Pediatr 171(78–82):e71 Chih WL, Wu PY, Sun LC, Lin MT, Wang JK, Wu MH (2016) Progressive coronary dilatation predicts worse outcome in Kawasaki disease. J Pediatr 171(78–82):e71
9.
go back to reference Lin MT, Sun LC, Wu ET, Wang JK, Lue HC, Wu MH (2015) Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous gamma-immunoglobulin therapy. Arch Dis Child 100:542–547CrossRefPubMed Lin MT, Sun LC, Wu ET, Wang JK, Lue HC, Wu MH (2015) Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous gamma-immunoglobulin therapy. Arch Dis Child 100:542–547CrossRefPubMed
10.
go back to reference Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW (2016) Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. J Am Heart Assoc 5:e003289CrossRefPubMedPubMedCentral Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW (2016) Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. J Am Heart Assoc 5:e003289CrossRefPubMedPubMedCentral
11.
go back to reference Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379–1385CrossRefPubMed Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379–1385CrossRefPubMed
12.
go back to reference Ghoshhajra BB, Lee AM, Engel LC, Celeng C, Kalra MK, Brady TJ, Hoffmann U, Westra SJ, Abbara S (2014) Radiation dose reduction in pediatric cardiac computed tomography: experience from a tertiary medical center. Pediatr Cardiol 35:171–179CrossRefPubMed Ghoshhajra BB, Lee AM, Engel LC, Celeng C, Kalra MK, Brady TJ, Hoffmann U, Westra SJ, Abbara S (2014) Radiation dose reduction in pediatric cardiac computed tomography: experience from a tertiary medical center. Pediatr Cardiol 35:171–179CrossRefPubMed
13.
go back to reference Dietz SM, Tacke CE, Kuipers IM, Wiegman A, de Winter RJ, Burns JC, Gordon JB, Groenink M, Kuijpers TW (2015) Cardiovascular imaging in children and adults following Kawasaki disease. Insights Imaging: 6: 697–705CrossRefPubMedPubMedCentral Dietz SM, Tacke CE, Kuipers IM, Wiegman A, de Winter RJ, Burns JC, Gordon JB, Groenink M, Kuijpers TW (2015) Cardiovascular imaging in children and adults following Kawasaki disease. Insights Imaging: 6: 697–705CrossRefPubMedPubMedCentral
14.
go back to reference Furuyama H, Odagawa Y, Katoh C, Iwado Y, Ito Y, Noriyasu K, Mabuchi M, Yoshinaga K, Kuge Y, Kobayashi K, Tamaki N (2003) Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J Pediatr 142:149–154CrossRefPubMed Furuyama H, Odagawa Y, Katoh C, Iwado Y, Ito Y, Noriyasu K, Mabuchi M, Yoshinaga K, Kuge Y, Kobayashi K, Tamaki N (2003) Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J Pediatr 142:149–154CrossRefPubMed
15.
go back to reference Dionne A, Ibrahim R, Gebhard C, Bakloul M, Selly JB, Leye M, Dery J, Lapierre C, Girard P, Fournier A, Dahdah N (2015) Coronary wall structural changes in patients with Kawasaki disease: new insights from optical coherence tomography (OCT). J Am Heart Assoc 4:e001939CrossRefPubMedPubMedCentral Dionne A, Ibrahim R, Gebhard C, Bakloul M, Selly JB, Leye M, Dery J, Lapierre C, Girard P, Fournier A, Dahdah N (2015) Coronary wall structural changes in patients with Kawasaki disease: new insights from optical coherence tomography (OCT). J Am Heart Assoc 4:e001939CrossRefPubMedPubMedCentral
Metadata
Title
Regression and Complications of z-score-Based Giant Aneurysms in a Dutch Cohort of Kawasaki Disease Patients
Authors
S. M. Dietz
I. M. Kuipers
J. C. D. Koole
J. M. P. J. Breur
Z. Fejzic
S. Frerich
M. Dalinghaus
A. A. W. Roest
B. A. Hutten
T. W. Kuijpers
Publication date
01-04-2017
Publisher
Springer US
Published in
Pediatric Cardiology / Issue 4/2017
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-017-1590-0

Other articles of this Issue 4/2017

Pediatric Cardiology 4/2017 Go to the issue